Literature DB >> 35146061

Dystonia Due to GM3 Synthase Deficiency.

Alexander S Wang1,2, Camilla Kilbane1,2.   

Abstract

BACKGROUND: Gangliosides are expressed in neuronal membranes, and play roles in neuronal differentiation and cell regulation during brain development. The ST3GAL5 gene encodes the enzyme GM3 synthase, and its deficiency causes a rare condition described to cause refractory epilepsy, profound intellectual disability, quadriplegia, choreoathetosis, and pigmentary skin changes. GM3 synthase deficiency is rarely reported to cause dystonia. We report five cases of GM3 synthase deficiency involving a dystonic phenotype. CASES: The five reported individuals were born of unaffected consanguineous parents from Old Order Amish families. They all developed refractory epilepsy and developmental regression within the first few months of life. They exhibit variable degrees of extrapyramidal movements, including orofacial, cervical, and limb dystonia, as well as choreoathetosis.
CONCLUSIONS: We report five individuals with GM3 synthase deficiency who developed dystonic features. Dystonia has previously been reported in only one case of GM3 synthase deficiency.
© 2021 International Parkinson and Movement Disorder Society.

Entities:  

Keywords:  Amish; GM3; congenital; dystonia; glycosylation

Year:  2022        PMID: 35146061      PMCID: PMC8810422          DOI: 10.1002/mdc3.13399

Source DB:  PubMed          Journal:  Mov Disord Clin Pract        ISSN: 2330-1619


  10 in total

1.  Hyperkinetic movement disorders in congenital disorders of glycosylation.

Authors:  G Mostile; R Barone; A Nicoletti; R Rizzo; D Martinelli; L Sturiale; A Fiumara; J Jankovic; M Zappia
Journal:  Eur J Neurol       Date:  2019-06-21       Impact factor: 6.089

2.  A mutation in a ganglioside biosynthetic enzyme, ST3GAL5, results in salt & pepper syndrome, a neurocutaneous disorder with altered glycolipid and glycoprotein glycosylation.

Authors:  Luigi Boccuto; Kazuhiro Aoki; Heather Flanagan-Steet; Chin-Fu Chen; Xiang Fan; Frank Bartel; Marharyta Petukh; Ayla Pittman; Robert Saul; Alka Chaubey; Emil Alexov; Michael Tiemeyer; Richard Steet; Charles E Schwartz
Journal:  Hum Mol Genet       Date:  2013-09-10       Impact factor: 6.150

3.  Expanding the phenotype of phosphomannomutase-2 gene congenital disorder of glycosylation: Cervical dystonia.

Authors:  Malco Rossi; Alex Medina Escobar; Lucia Ameghino; Marcelo Merello
Journal:  J Neurol Sci       Date:  2017-04-23       Impact factor: 3.181

4.  ST3GAL5-Related Disorders: A Deficiency in Ganglioside Metabolism and a Genetic Cause of Intellectual Disability and Choreoathetosis.

Authors:  Eliza Gordon-Lipkin; Julie S Cohen; Siddharth Srivastava; Bruno P Soares; Eric Levey; Ali Fatemi
Journal:  J Child Neurol       Date:  2018-09-05       Impact factor: 1.987

5.  GM3 synthase deficiency due to ST3GAL5 variants in two Korean female siblings: Masquerading as Rett syndrome-like phenotype.

Authors:  Jin Sook Lee; Yongjin Yoo; Byung Chan Lim; Ki Joong Kim; Junghan Song; Murim Choi; Jong-Hee Chae
Journal:  Am J Med Genet A       Date:  2016-05-27       Impact factor: 2.802

6.  Refractory epilepsy and mitochondrial dysfunction due to GM3 synthase deficiency.

Authors:  Konstantina Fragaki; Samira Ait-El-Mkadem; Annabelle Chaussenot; Catherine Gire; Raymond Mengual; Laurent Bonesso; Marie Bénéteau; Jean-Ehrland Ricci; Valérie Desquiret-Dumas; Vincent Procaccio; Agnès Rötig; Véronique Paquis-Flucklinger
Journal:  Eur J Hum Genet       Date:  2012-09-19       Impact factor: 4.246

7.  Infantile-onset symptomatic epilepsy syndrome caused by a homozygous loss-of-function mutation of GM3 synthase.

Authors:  Michael A Simpson; Harold Cross; Christos Proukakis; David A Priestman; David C A Neville; Gabriele Reinkensmeier; Heng Wang; Max Wiznitzer; Kay Gurtz; Argyro Verganelaki; Anna Pryde; Michael A Patton; Raymond A Dwek; Terry D Butters; Frances M Platt; Andrew H Crosby
Journal:  Nat Genet       Date:  2004-10-24       Impact factor: 38.330

Review 8.  The role of glycosphingolipid metabolism in the developing brain.

Authors:  Robert K Yu; Yoshihiko Nakatani; Makoto Yanagisawa
Journal:  J Lipid Res       Date:  2008-10-09       Impact factor: 5.922

9.  Early growth and development impairments in patients with ganglioside GM3 synthase deficiency.

Authors:  H Wang; A Wang; D Wang; A Bright; V Sency; A Zhou; B Xin
Journal:  Clin Genet       Date:  2016-01-20       Impact factor: 4.438

Review 10.  Sialic acids in the brain: gangliosides and polysialic acid in nervous system development, stability, disease, and regeneration.

Authors:  Ronald L Schnaar; Rita Gerardy-Schahn; Herbert Hildebrandt
Journal:  Physiol Rev       Date:  2014-04       Impact factor: 37.312

  10 in total
  1 in total

Review 1.  The apparent paradox of phenotypic diversity and shared mechanisms across dystonia syndromes.

Authors:  Alessio Di Fonzo; Alberto Albanese; Hyder A Jinnah
Journal:  Curr Opin Neurol       Date:  2022-07-05       Impact factor: 6.283

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.